Chongqing Baiya Sanitary Products (SZSE:003006) Stock Valuation, Peer Comparison & Price Targets

Q: What is the Fair Price of 003006 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

003006 (CN¥26.68) is trading below our estimate of [[fair value]] (CN¥32.89)

Share Price vs Fair Value

What is the Fair Price of 003006 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 003006 (CN¥26.68) is trading below our estimate of fair value (CN¥32.89)

Significantly Below Fair Value: 003006 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 003006?

Key metric: As 003006 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 003006. This is calculated by dividing 003006's market cap by their current earnings.
What is 003006's PE Ratio?
PE Ratio	38.9x
Earnings	CN¥294.38m
Market Cap	CN¥11.41b

003006 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.6x
Enterprise Value/EBITDA	28.8x
PEG Ratio	1.5x

Price to Earnings Ratio vs Peers

How does 003006's PE Ratio compare to its peers?

The above table shows the PE ratio for 003006 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	32.3x
603193 Runben Biotechnology	31.6x	22.7%	CN¥9.8b
603983 Guangdong Marubi Biotechnology	36.5x	24.0%	CN¥12.4b
300791 Sirio Pharma	18.4x	21.1%	CN¥6.2b
600315 Shanghai Jahwa United	42.6x	27.5%	CN¥11.6b
003006 Chongqing Baiya Sanitary Products	38.9x	26.1%	CN¥11.4b

Price-To-Earnings vs Peers: 003006 is expensive based on its Price-To-Earnings Ratio (38.9x) compared to the peer average (32.3x).

Price to Earnings Ratio vs Industry

How does 003006's PE Ratio compare vs other companies in the CN Personal Products Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 003006 is expensive based on its Price-To-Earnings Ratio (38.9x) compared to the CN Personal Products industry average (34.7x).

Price to Earnings Ratio vs Fair Ratio

What is 003006's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

003006 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	38.9x
Fair PE Ratio	28.6x

Price-To-Earnings vs Fair Ratio: 003006 is expensive based on its Price-To-Earnings Ratio (38.9x) compared to the estimated Fair Price-To-Earnings Ratio (28.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 003006 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CN¥26.68	CN¥28.50 +6.8%	1.8%	CN¥29.00	CN¥28.00	n/a	2
Nov ’25	CN¥25.85	CN¥28.50 +10.3%	1.8%	CN¥29.00	CN¥28.00	n/a	2
Oct ’25	CN¥26.69	CN¥25.50 -4.5%	5.9%	CN¥27.00	CN¥24.00	n/a	2
Sep ’25	CN¥22.60	CN¥25.50 +12.8%	5.9%	CN¥27.00	CN¥24.00	n/a	2
Aug ’25	CN¥20.86	CN¥22.25 +6.7%	5.6%	CN¥23.50	CN¥21.00	n/a	2
Jul ’25	CN¥24.05	CN¥22.25 -7.5%	5.6%	CN¥23.50	CN¥21.00	n/a	2
Jun ’25	CN¥23.61	CN¥22.25 -5.8%	5.6%	CN¥23.50	CN¥21.00	n/a	2
May ’25	CN¥21.60	CN¥22.25 +3.0%	5.6%	CN¥23.50	CN¥21.00	n/a	2
Apr ’25	CN¥16.62	CN¥20.00 +20.3%	10.0%	CN¥22.00	CN¥18.00	n/a	2
Mar ’25	CN¥16.15	CN¥20.00 +23.8%	10.0%	CN¥22.00	CN¥18.00	n/a	2
Feb ’25	CN¥13.58	CN¥20.00 +47.3%	10.0%	CN¥22.00	CN¥18.00	n/a	2
Jan ’25	CN¥15.16	CN¥20.00 +31.9%	10.0%	CN¥22.00	CN¥18.00	n/a	2
Dec ’24	CN¥16.07	CN¥20.77 +29.2%	9.4%	CN¥22.30	CN¥18.00	n/a	3
Nov ’24	CN¥16.94	CN¥20.77 +22.6%	9.4%	CN¥22.30	CN¥18.00	CN¥25.85	3
Oct ’24	CN¥14.75	CN¥20.77 +40.8%	9.4%	CN¥22.30	CN¥18.00	CN¥26.69	3
Sep ’24	CN¥14.06	CN¥20.77 +47.7%	9.4%	CN¥22.30	CN¥18.00	CN¥22.60	3
Aug ’24	CN¥15.83	CN¥21.77 +37.5%	2.6%	CN¥22.30	CN¥21.00	CN¥20.86	3
Jul ’24	CN¥17.28	CN¥21.77 +26.0%	2.6%	CN¥22.30	CN¥21.00	CN¥24.05	3
Jun ’24	CN¥17.50	CN¥21.77 +24.4%	2.6%	CN¥22.30	CN¥21.00	CN¥23.61	3
May ’24	CN¥18.43	CN¥21.77 +18.1%	2.6%	CN¥22.30	CN¥21.00	CN¥21.60	3
Apr ’24	CN¥18.13	CN¥20.72 +14.3%	5.7%	CN¥22.00	CN¥19.15	CN¥16.62	3
Mar ’24	CN¥18.98	CN¥19.38 +2.1%	10.6%	CN¥22.00	CN¥17.00	CN¥16.15	3
Feb ’24	CN¥17.29	CN¥18.22 +5.4%	4.9%	CN¥19.15	CN¥17.00	CN¥13.58	3
Jan ’24	CN¥13.81	CN¥13.10 -5.1%	3.8%	CN¥13.60	CN¥12.60	CN¥15.16	2
Dec ’23	CN¥13.71	CN¥13.10 -4.4%	3.8%	CN¥13.60	CN¥12.60	CN¥16.07	2
Nov ’23	CN¥10.85	CN¥13.10 +20.7%	3.8%	CN¥13.60	CN¥12.60	CN¥16.94	2

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

SYoung Group

CN¥5.0b

Engages in the research and development, production, and sale of cosmetic products in China.

300740

CN¥12.82

7D

-7.7%

1Y

-19.4%

Byhealth

CN¥21.7b

Develops and sells dietary supplements.

300146

CN¥12.90

7D

-5.4%

1Y

-28.4%

Sirio Pharma

CN¥6.2b

Operates as a contract manufacturer for dietary supplement industry worldwide.

300791

CN¥26.60

7D

-5.6%

1Y

2.7%

Chongqing Baiya Sanitary Products Valuation